Publisher
Springer Science and Business Media LLC
Reference6 articles.
1. St. Lochli, Campbell, I., Dorenboos, H., Paterson, K. R., Devlin, J. G., Hagmuller, G., Irsigler, K. Behandlung der Resistenz gegen subkutanes Insulin mit implantierten Insulin- Infusionspumpen. DMW 1988: 113. Jg., Nr. 36 Pg. 1390.
2. Irsigler, K., Krits, H., Hagmueller, G., Najemnik, C., Lovett, R. Implanted constant basal rate insulin infusion systems for Type I diabetic patients. Diabetes treatment with implantable insulin infusion systems. 1983: Edited: Irsigler, K., Kritz, H., Lovett, R. 6; 52-63.
3. Saudek, C., Selam, J., Pitt, H., Waxman, K., Rubio, M., Jeandidier, N., Turner, O., Fishell, R., Charles, M. A. Preliminary trial of programmable implantable medication system for insulin delivery. N. Engl. J. Med. 1989: 321: 9: 574–80.
4. Fonseca, V. A., Menon, R. K., O’Brien, A. S., Fernando, O. W., Stephen, R., Dandona, P. Diabetic pregnancy managed with intraperitoneal pump - Case Report. Diabetic Medicine 1987: 4, 74–76.
5. Gennaro, W. D., Van Norman, J. D. Quantitation of free, total, and antibody-bound insulin in insulin-treated diabetics. Clin. Chem. 1975: 21: 7, 873–879.